Oncology
400mg Veenat Imatinib Tablets IP
Veenat Imatinib
Targeted therapy oral solid: Veenat Imatinib (400mg) by NexCure Health. GMP-certified for international export.
Dosage
400mg
Composition
Veenat Imatinib 400mg
Packaging
10 Tablets per strip
Manufacturer
NexCure Health
$19.46per tablet
In Stock — Ships within 24hrs
Worldwide shipping
CoA included
Quantity:
1
💡 Bulk pricing available — Contact us for orders of 100+ units for additional discounts. All orders include Certificate of Analysis and export documentation.
400mg Veenat Imatinib Tablets IP — a WHO-GMP certified targeted therapy product from NexCure Health. Active composition: Veenat Imatinib 400mg. Pharmacological action: tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity. Clinical use: chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Every batch is quality-verified with HPLC assay, content uniformity, and accelerated stability testing. Supplied with full Certificate of Analysis and export documentation for international pharmaceutical trade.
